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Previous research points to the heritability of risk-taking behaviour. However, evidence 39 
on how genetic dispositions are translated into risky behaviour is scarce. Here, we 40 
report a genetically-informed neuroimaging study of real-world risky behaviour across 41 
the domains of drinking, smoking, driving, and sexual behaviour, in a European sample 42 
from the UK Biobank (N=12,675). We find negative associations between risky 43 
behaviour and grey matter volume (GMV) in distinct brain regions, including amygdala, 44 
ventral striatum, hypothalamus, and dorsolateral prefrontal cortex (dlPFC). These 45 
effects replicate in an independent sample recruited from the same population 46 
(N=13,004). Polygenic risk scores for risky behaviour, derived from a genome-wide 47 
association study in an independent sample (N=297,025), are inversely associated with 48 
GMV in dlPFC, putamen, and hypothalamus. This relation mediates ~2.2% of the 49 
association between genes and behaviour. Our results highlight distinct heritable 50 
neuroanatomical features as manifestations of the genetic propensity for risk taking. 51 





Taking risks—an essential element of many human experiences and 54 
achievements—requires balancing uncertain positive and negative outcomes. For 55 
instance, exploration, innovation and entrepreneurship can yield great benefits, but are 56 
also prone to failure1. Conversely, excessive risk-taking in markets can have enormous 57 
societal costs, such as the generation of speculative price bubbles2. Similarly, common 58 
behaviours such as smoking, drinking, sexual promiscuity, or speeding are considered 59 
rewarding by many but might expose individuals and those around them to deleterious 60 
health, social, and financial consequences. In 2010, the combined economic burden in 61 
the United States of these risky behaviours was estimated to be about $593.3 billion3–6. 62 
Although previous findings point to the partial heritability of risk tolerance and risky 63 
behaviours7 and neuroanatomical measures exhibit high heritability8,9, little is known 64 
about the brain features involved in translating genetic dispositions into risky 65 
behavioural phenotypes8. 66 
Recent research using structural brain-imaging data from small, non-67 
representative samples (comprising up to a few hundred participants) has identified 68 
several neuroanatomical associations with risk tolerance10–12. However, this literature is 69 
limited by low statistical power13,14, and the generalizability of their findings to other 70 
populations is questionable. Small sample sizes have also limited the ability to control 71 
systematically for many factors that could confound observed relations between brain 72 
features and risky behaviour, such as height15 and genetic population structure16,17. 73 
Moreover, despite evidence that the effects of genetic factors are likely mediated by 74 
their influence on the brain and its development7,18, neuroscientific and genetic 75 




isolation–perhaps due to the lack of large study samples that include both genetic and 77 
brain imaging measures. 78 
Here, we utilize data obtained in a prospective epidemiological study of ~500,000 79 
individuals aged 40 to 69 years [the UK Biobank (UKB)19,20] to carry out a pre-registered 80 
investigation (https://osf.io/qkp4g/, see Supplementary Methods for deviations from the 81 
analysis plan) of the relationship between individual differences in brain anatomy and 82 
the propensity to engage in risky behaviour across four domains (N=12,675, for sample 83 
characteristics see Figure 1 and Extended Data Figure 1). We replicate our findings in 84 
an independent sample recruited from the same population (N=13,004, for sample 85 
characteristics see Extended Data Figure 2). Further, we isolate specific differences in 86 
brain anatomy that are linked to the genetic disposition for risky behaviour— quantified 87 
via polygenic risk scores (PRS) derived from a genome-wide association study (GWAS) 88 
in an independent sample (N = 297,025)—and investigate how these neuroanatomical 89 
endophenotypes mediate the influence of genetics on the behavioural phenotype. 90 
 91 
Results 92 
Grey Matter Volume Associations with Risky Behaviour 93 
Akin to a previous investigation7, we construct a measure of risky behaviour by 94 
extracting the first principal component from four self-reported measures of drinking, 95 
smoking, speeding on motorways, and sexual promiscuity (N = 315,855; see Figure 2A, 96 
Supplementary Methods 1.1and Supplementary Tables 1-2 for descriptive statistics). 97 
This measure of risky behaviour is genetically correlated with many other traits, 98 
including cannabis use (rg = 0.72, SE = 0.02), general risk tolerance (rg = 0.56, SE = 99 
0.02), self-employment (rg = 0.52; SE = 0.30), suicide attempt (rg = 0.47, SE = 0.07), 100 




at first sexual experience (rg = -0.54, SE = 0.02) (Supplementary Methods 1.5 and 102 
Supplementary Table 3). Thus, our measure is partly rooted in genetic differences 103 
between people and relates to a broad range of relevant events and behaviours. 104 
Our main analysis includes a sample of 12,675 European-ancestry participants 105 
from the UKB. We first regress our measure of risky behaviour on total (whole-brain) 106 
grey matter volume (GMV) while controlling for age, birth year, gender, handedness, 107 
height, total intracranial volume and the first 40 genetic principal components, which 108 
account for genetic population structure (see Supplementary Methods 1.2). To exclude 109 
confounding effects of excessive alcohol consumption21, we excluded from the analysis 110 
all current or former heavy drinkers (see Methods)22,23. We find an inverse association 111 
between total GMV and risky behaviour (standardized β = −.122; 95% confidence 112 
interval (CI) [−.156, −.087]; t(12,561) = −6.92; P < 4.86 × 10−12, two-sided). 113 
To identify specific brain regions related to risky behaviour, we perform a whole-114 
brain voxel-based morphometry (VBM)24 analysis that regresses our measure of risky 115 
behaviour separately on GMV in each voxel across the brain, adjusting for the same 116 
control variables. We identify localized inverse associations between risky behaviour 117 
and GMV in distinct regions, only some of which were expected based on previous 118 
small-scale studies (see Figure 2B, Extended Data Figure 3 and Supplementary Table 119 
4). In subcortical areas, we identify associations bilaterally in expected areas such as 120 
the amygdala and ventral striatum (VS), as well as in less expected areas such as the 121 
posterior hippocampus, putamen, thalamus, hypothalamus, and cerebellum. We also 122 
identify bilateral associations between risky behaviour and GMV in cortical regions that 123 
include the ventral medial prefrontal cortex (vmPFC), dorsolateral prefrontal cortex 124 




GMV is negatively associated with the propensity to engage in risky behaviours. We find 126 
no positive associations between GMV and risky behaviour anywhere in the brain. 127 
To quantify effect sizes of the associations between risky behaviour and GMV in 128 
anatomically-defined brain structures and to investigate the convergence of our findings 129 
across MRI processing pipelines25, we conduct a follow-up analysis at the region of 130 
interest (ROI) level. This analysis primarily relies on the imaging-derived phenotypes 131 
(IDPs) provided by the UKB brain imaging processing pipeline8,26,27, which used 132 
parcellations from the Harvard-Oxford cortical and subcortical atlases and the 133 
Diedrichsen cerebellar atlas. We derived additional IDPs using unbiased masks based 134 
on the results of the voxel-level analysis (see Supplementary Methods 1.3.3). This 135 
analysis identifies negative associations between risky behaviour and GMV in 23 136 
anatomical structures, with standardized βs between −0.079 and −0.036 (see Figure 137 
2C, Extended Data Figure 4 and Supplementary Table 5; for the associations between 138 
the IDPs and the individual measures that construct our phenotype of Risky Behavior, 139 
see Supplementary Table 6), the largest of which is in the right ventro-aINS; (β = 140 
−0.079; 95% CI [−.103, −.055]; t(12,562) = −6.43; Puncorr = 1.34 × 10-10, two-sided). 141 
We carry out several additional analyses to assess the differential contributions 142 
of various factors to the associations we observe. First, we re-estimate the ROI-level 143 
regressions with additional controls for various socioeconomic and cognitive outcomes 144 
that may be linked to both brain anatomy and risky behaviour, either as antecedents or 145 
downstream consequences. These controls include participants' years of education and 146 
fluid intelligence (13-item measure)17, a zip-code level measure of the Townsend social 147 
deprivation index28, household income and size, and birth location binned into 100 148 
geographical clusters (see Supplementary Methods 1.2 and Figure 1). The direction and 149 




βs between −0.079 and −0.035), with the largest effect again located in the right ventro-151 
aINS (β = −0.079; 95% CI [−.104, −.055]; t(11,647) = −6.29; Puncorr = 3.3 × 10-10, two-152 
sided). Furthermore, 19 of the 23 ROIs (all except the left Cuneal Cortex, left Crus I of 153 
the Cerebellum, left Planum Polare and the Brain Stem) are statistically significant after 154 
correction for multiple comparisons in this analysis (see Extended Data Figure 5 and 155 
Supplementary Table 5). 156 
Second, we re-estimate our ROI-level regressions with additional controls for 157 
current levels of drinking (binned into 10 deciles) and smoking (binned into 3 158 
categories). Although introducing these controls into the model regresses out variance 159 
of interest from the main outcome measure, which likely attenuates the effects, this 160 
analysis allows us to test whether any of the identified associations can reliably be 161 
attributed to risky behaviour that is not limited to the substance-use domain. In this 162 
analysis, we find that all of the effects originally identified remain negative in sign, yet 163 
are smaller in magnitude (range of standardized βs between −0.041 and −0.011; see 164 
Supplementary Table 7). Nonetheless, the effects in 9 subcortical ROIs (including the 165 
Amygdala, Putamen, VS and Cerebellum) remain statistically significant after correction 166 
for multiple comparisons (see Extended Data Figure 6), with the strongest association 167 
identified in the left Amygdala (β = −0.041; 95% CI [-0.059, -0.023]; t(12,551) = −4.4; 168 
Puncorr = 1.1 × 10
-5, two-sided). Thus, these subcortical IDPs are reliably associated with 169 
risky behaviour in non-substance use domains. 170 
 171 
Replication in an Independent Sample  172 
Several months after the completion of our original analyses (in February 2020; 173 
https://biobank.ndph.ox.ac.uk/showcase/exinfo.cgi?src=timelines), the UKB released 174 




replicate our findings in an independent dataset that contains the same variables, and 176 
participants recruited in the same way from the same population29. After applying the 177 
same exclusion criteria as in our original analysis, our replication sample consists of 178 
13,004 participants, roughly the same size as our original sample (see Methods for 179 
details and Extended Figure 1 for sample characteristics). We repeat both the voxel-180 
level and ROI-level analyses in this dataset. In the voxel-level analysis, we apply a 181 
significance threshold that corresponds to a family-wise-error (FWE) rate of 5% in all 182 
voxels that showed significance in the original analysis (puncorr = 2.956 x 10
-04, with 183 
tuncorr(12,892) = 3.62, two-sided). We find that 92.6% of the original voxels (located in 20 184 
of the 21 clusters originally identified, with the exception of a cluster in cerebellar 185 
lobules I-IV) successfully replicate (see Figure 3). Furthermore, the un-thresholded t-186 
map25 of the original dataset strongly correlates with the un-thresholded t-map of the 187 
replication dataset (r = .767; 95% CI [.766, .768]; P < 10-10, two-sided). Likewise, our 188 
ROI-level analysis successfully replicates 21 of the original 23 ROI-level findings (puncorr 189 
= 3.35 x 10-03, with tuncorr(12,892) = 2.93, two-sided; see Supplementary Table 8). The 190 
two ROIs that do not replicate are the Cuneal Cortex (left) and the cerebellar lobule II 191 
(left). 192 
Overlap between Grey Matter Volume Differences and Functional MRI (fMRI) Meta-193 
Analysis 194 
To investigate whether the neuroanatomical associations of real-world risky 195 
behaviour correspond spatially with the localized activation patterns commonly identified 196 
in fMRI studies of risky decision-making, we conduct a conjunction analysis to compare 197 
our VBM results with data obtained from a publicly available meta-analysis of fMRI 198 
studies of risky behaviour30 (N = 4,717 participants, K = 101 individual studies, see 199 




associations with risky behaviour converge with functional engagement, including the 201 
thalamus, amygdala, vmPFC, and dlPFC (see Figure 4 and Extended Data Figure 7). 202 
 203 
Association of Polygenic Risk Scores for Risky Behaviour with Grey Matter 204 
Volume 205 
Finally, we explore whether participants’ genetic disposition for risky behaviour, 206 
proxied via their polygenic risk scores (PRS), are associated with the neuroanatomical 207 
correlates of the trait, and test whether these neuroanatomical correlates mediate the 208 
relationship between genetic predisposition and behaviour. To this end, we first 209 
conducted a GWAS in an independent sample of UKB participants of European 210 
ancestry (N=297,025), exclusive of 18,796 genotyped individuals with usable MRI 211 
images (main sample) and their relatives. From the GWAS, we constructed a PRS that 212 
aggregated the effects of 1,176,729 single nucleotide polymorphisms (SNPs) on risky 213 
behaviour for all of the participants with MRI data in our independent target sample (see 214 
Supplementary Methods 1.4). The PRS predicts ~3% of the variance in risky behaviour 215 
in our target sample. Although we find no statistically significant evidence to suggest 216 
that the PRS are associated with whole-brain GMV (standardized β = −.015; 95% CI [-217 
.05 .02]; t(12,561) = −0.82; P > 0.41, two-sided), they are inversely associated with 218 
GMV in distinct regions, specifically the right dlPFC, right putamen and hypothalamus 219 
(Figure 5A.; regressions include all standard control variables, including total intracranial 220 
volume). Thus, GMV in these specific brain areas is negatively associated with the 221 
genetic disposition for risky behaviour. 222 
Based on these results, we use the previously extracted GMV of these three 223 
ROIs to examine whether it mediates the observed gene-behaviour associations. A 224 




association between the PRS and risky behaviour is mediated through individual 226 
differences in GMV in the three regions (indirect path c’; standardized β = 0.004, 95%; 227 
CI [.002, .005]; z = 4.83; P = 1.4 × 10-06, two-sided) (see Figure 5B and Extended Data 228 
Figure 8). 229 
Discussion 230 
We investigate in a genetically-informed neuroimaging study (a) the association 231 
between GMV and real-world risky behaviour in a large population sample of European 232 
ancestry (main sample of 12,675 individuals and replication sample of 13,004 233 
individuals), and (b) how the genetic disposition for risky behaviour is linked to GMV 234 
differences in a network of distinct brain areas. Several of the areas whose GMVs are 235 
linked to risky behaviour in this study have also often been functionally engaged during 236 
risky decision-making in small-scale fMRI studies that used stylized tasks. For instance, 237 
such correlations have been observed in the aINS, thalamus, dlPFC, vmPFC and 238 
VS31,32. These findings have led to proposals that upward and downward risks are 239 
encoded by distinct circuits, with upward risk mainly represented by areas encoding 240 
rewards (VS and vmPFC) and downward risk encoded by areas related to avoidance 241 
and negative arousal (aINS). Here, we substantiate previous functional studies with 242 
large-scale evidence that the structural properties of the same areas relate to risky 243 
behaviour in an ecologically valid setting33 when long-term health consequences are at 244 
stake. 245 
Our results extend previous findings by showing that the neural foundation of 246 
risky behaviour is complex. Our analyses identify additional negative associations 247 
between risky behaviour and GMV in several areas, including the cerebellum, posterior 248 
hippocampus, hypothalamus, and putamen. While it is not yet clear how structural 249 




taking draws on manifold neural processes, not just the representation and integration 251 
of upward and downward risks in the brain. Specifically, considering previous meta-252 
analyses, the areas identified in this study are involved broadly in memory (posterior 253 
hippocampus), emotion processing (amygdala, ventro-aINS)35, neuroendocrine 254 
processes (hypothalamus)36,37, reward processing (vmPFC, VS and putamen)38 and 255 
executive functions (dlPFC)39. Thus, it appears that risky behaviour taps into multiple 256 
elements of human cognition, ranging from inhibitory control40 to emotion regulation41 257 
and the integration of outcomes and risks42. This mirrors previous findings showing that 258 
risky behaviour is also a genetically complex trait7.  259 
Additionally, our results underscore the long-suspected role of the hypothalamic–260 
pituitary–adrenal (HPA) axis in regulating risk-related behaviours, in line with hormonal 261 
studies that link risky behaviour and sensation seeking to stress responsivity36,37,43–45. 262 
Furthermore, our finding that risky behaviour is linked to the structure of several 263 
cerebellar areas confirms the under-appreciated importance of the cerebellum for 264 
human cognition and decision-making, and highlights the need for further research on 265 
the specific behavioural contributions of this brain area46.  266 
Of note, it remains an open question the extent to which the differences in GMV 267 
that we identify can be ascribed to specific heritable micro-anatomical traits, such as 268 
neuronal size, dendritic or axonal arborisation, or relative count of different cell types47. 269 
Moreover, it is not yet clear how these individual differences, in turn, influence 270 
behaviour. Nonetheless, our results provide evidence that neuro-anatomical structure 271 
constitutes the micro-foundation for neuro-computational mechanisms underlying 272 
individual differences in risky behaviours34. 273 
Several of the observed neuroanatomical correlates of risky behaviour are also 274 




in the hypothalamus, the putamen and the dlPFC share variance with both risky 276 
behaviour and its polygenic risk score. This finding extends previous studies showing 277 
correlational36,42,43 and causal evidence37,48 of the involvement of these areas in risky 278 
behaviour by indicating that a genetic component partly underlies the associations. 279 
Although our analyses cannot identify the direction of the causal relationships (see 280 
Supplementary Discussion for an additional discussion of limitations), they show that 281 
risky behaviour and its genetic associations share variance with distinct GMV features 282 
and provide an overarching framework for how the genetic dispositions for risky 283 
behaviour may be expressed in the corresponding behavioural phenotype. 284 
Our results are also in line with the bioinformatic annotation of the largest GWAS 285 
on risk tolerance to date, conducted in over 1 million individuals7, which implicated 286 
specific areas in the prefrontal cortex (BA9, BA24), striatum, cerebellum and the 287 
amygdala. However, bioinformatics tools used for GWAS annotation cannot be 288 
considered conclusive, as they rely on gene expression patterns in relatively small 289 
samples of (post-mortem) human brains or non-human samples49. Moreover, they 290 
cannot speak to whether changes in a particular tissue or cell type have negative or 291 
positive effects on the phenotype or how strong the effects are. Here, we show an 292 
alternative approach to annotating GWAS findings using a different type of data (large-293 
scale population samples that include in-vivo brain scans and genetic data), relying on 294 
different assumptions than those used by bioinformatics tools. Our results add new 295 
insight by showing that lower GMV in specific brain areas is related to more risky 296 
behaviour and by implicating brain regions (i.e., putamen, hypothalamus, and dlPFC) in 297 
addition to those previously annotated. The effect sizes we observe here (standardized 298 
β < 0.08) are an order of magnitude larger than those found in GWAS on risky 299 




Finally, while many features of the brain are heritable, the environment 301 
indisputably plays an important role in brain development. We therefore see our results 302 
not as independent from, or of greater importance than, the effects of environmental 303 
and developmental factors. Rather, our study constitutes one step towards 304 
understanding how the complex development of human risky behaviour may be 305 
constrained by genetic factors. 306 
 307 
Methods 308 
Sample Characteristics and Selection Criteria 309 
Main sample. We use publicly available data from the UKB, which recruited 502,617 310 
people aged 40 to 69 years from the general population across the United Kingdom19,20. 311 
All UKB participants provided written informed consent and the study was granted 312 
ethical approval by the North West Multi-Centre Ethics committee. Our initial sample 313 
consists of 18,796 individuals with brain scans and genotype data, all of the imaged 314 
UKB participants as of October 2018. We excluded participants with putative sex 315 
chromosome aneuploidy (N = 6) or a mismatch between genetic and reported sex (N = 316 
10), participants of non-European ancestry (N = 893), and participants who did not pass 317 
the UKB quality-control thresholds (N = 14), described in Bycroft et al.27. To minimize 318 
the potential influence of neurotoxic effects due to excessive alcohol intake21,22, we also 319 
excluded current heavy drinkers (531 females consuming more than 18 drinks per week 320 
and 793 males consuming more than 24 drinks per week)22,23. To exclude potential 321 
former drinkers, we also removed 426 participants who indicated that they did not drink 322 
alcohol. 323 
All structural T1 MRI images used in the study underwent automated quality 324 




quality checks using the Computational Anatomy Toolbox (CAT; www.neuro.uni-326 
jena.de/cat/) for SPM 12 (www.fil.ion.ucl.ac.uk/spm/software/spm12/). First, we relied on 327 
the CAT12 automated Image and Pre-processing quality assessment, which included 328 
quality parameters for resolution, noise, and bias of images, 57 of which were 329 
automatically excluded and not pre-processed due to low image quality. Second, after 330 
pre-processing, we utilized an automated quality check of sample homogeneity to 331 
identify outliers that exhibited substantially different GMV patterns than the rest of the 332 
sample (see the CAT12 manual for details; http://www.neuro.uni-jena.de/cat12/CAT12-333 
Manual.pdf, p. 17ff). In total, we excluded 690 individuals with scans of high image 334 
inhomogeneity (two standard deviations below the mean). Finally, we excluded 2,701 335 
participants with incomplete behavioural data of interest or control variables. Our final 336 
dataset consists of N = 12,675 individuals. 337 
Replication sample. The initial replication sample consisted of 20,316 individuals with 338 
usable brain scans and genotype data, all of the imaged UKB participants as of 339 
February 2020 who were not included in our main sample. Following the original 340 
analysis, we excluded participants with putative sex chromosome aneuploidy (N = 7), a 341 
mismatch between genetic and reported sex (N = 11), non-European ancestry (N = 342 
1,143), heavy drinking or abstinence from alcohol (N = 1,376), and those that did not 343 
pass the UKB quality-control thresholds (N = 31)27. All T1 MRI images used in the study 344 
underwent the same quality control procedure as in our original sample, resulting in the 345 
removal of additional 391 individuals. Finally, we excluded participants with incomplete 346 
data (N = 4,353). Our final replication sample consists of N = 13,004. The empirical 347 
distributions of the variables characterizing our replication analysis are depicted in 348 





Risky Behaviour. We closely follow Karlsson Linnér et al.7 to derive a measure of risky 351 
behaviour across domains based on participants’ self-reports of: (1) Number of alcoholic 352 
drinks per week, (2) Ever having smoked, (3) Number of sexual partners, and (4) 353 
Frequency of driving faster than the motorway speed limit (see Supplementary Methods 354 
1.1). We perform principal component analysis (PCA) on N = 315,855 UKB participants 355 
and extract the first principal component (PC) of the four measures as the main 356 
outcome of interest (referred to as “risky behaviour”). The first PC explains ~37% of the 357 
variance in the four measures, and it is the only PC that loads positively on all of them. 358 
Summary statistics and factor loadings of the PCA are available in Supplementary 359 
Tables 1 and 2. The code for generating the variable of ‘risky behaviour’ is accessible at 360 
https://osf.io/qkp4g/. 361 
Control variables. The full list of control variables and the methods used to generate 362 
them are available in Supplementary Methods 1.2.  363 
T1 MRI Image Processing. We use T1-weighted structural brain MRI images in NIFTI 364 
format provided by the UKB. Images were acquired using 3-T Siemens Skyra scanners, 365 
with a 32-channel head coil (Siemens, Erlangen, Germany), with the following scanning 366 
parameters: repetition time = 2000 ms; echo time = 2.1 ms; flip angle = 8°; matrix size = 367 
256 × 256 mm; voxel size = 1 × 1 × 1 mm; number of slices = 208. A detailed 368 
description of the methods used to pre-process the images and derive voxel-level and 369 
ROI-level IDPs is available in Supplementary Methods 1.3.1-1.3.3.  370 
Polygenic Risk Score (PRS) for Risky Behaviour. To construct a PRS, we first re-371 
estimated the GWAS of our main measure described in ref7 after excluding 18,796 372 
genotyped individuals with usable T1 MRI images and their relatives up to the third 373 
degree (final GWAS sample: N = 297,025 individuals of European ancestry). The 374 




version 2.3.250. Next, we performed quality control (QC) of the GWAS results using a 376 
standardized QC protocol, described in detail in ref7. This protocol removes rare and 377 
low-quality single-nucleotide polymorphisms (SNPs) based on minor allele frequency 378 
(MAF) < 0.001, imputation quality (INFO) < 0.7, and SNPs that could not be aligned with 379 
the Haplotype Reference Consortium (HRC) reference panel, among other filters. After 380 
QC, a total of 11,514,220 SNPs remained in the GWAS summary statistics. Thereafter, 381 
we calculated a PRS for each participant by weighting their genotype across SNPs by 382 
the corresponding regression coefficients estimated in the GWAS (see Supplementary 383 
Methods 1.4 for further information).  384 
Analysis 385 
Voxel-based Morphometry (VBM). We identify associations between risky behaviour 386 
and localized GMV across the brain using whole-brain voxel-based morphometry 387 
(VBM), a method that normalizes the anatomical brain images of all participants in one 388 
stereotactic space24. We regress risky behaviour separately on each voxel of the 389 
smoothed GMV images (see Supplementary Methods 1.3.1) and the control variables. 390 
We correct for multiple comparisons by adjusting the FWE rate to α = 0.01 using 391 
permutation tests (puncorr = 1.248 x 10
-06, with |tuncorr| = 4.85, two-sided). See Extended 392 
Data Figure 3 and Supplementary Table 4 for the summary statistics of each cluster and 393 
the coordinates of the peak voxel within that cluster. 394 
Region of Interest (ROI)-level Analysis. We compute the associations between risky 395 
behaviour and 139 IDPs of GMV extracted by the UKB brain imaging processing 396 
pipeline26 using parcellations from the Harvard-Oxford cortical and subcortical atlases 397 
and Diedrichsen cerebellar atlas, in addition to 9 IDPs derived using unbiased masks 398 
based on the results of our voxel-level analysis (see Supplementary Methods 1.3.2 and 399 




and correct for multiple comparisons by adjusting the FWE rate of α = 0.01 using 401 
permutation tests (puncorr = 9.37 x 10
-05, with |tuncorr|= 3.91, two-sided). 402 
Replication of the Voxel-level and ROI-level Analyses. We repeat the VBM analyses 403 
in the replication sample for all voxels that showed significance in the original sample, 404 
correcting for multiple comparisons by adjusting the FWE rate to α = 0.05 (two-tailed) 405 
using permutation tests (puncorr = 2.956 x 10
-04, with tuncorr = 3.62). We also repeat the 406 
ROI-level analysis in all ROIs that showed significance in the original sample, and 407 
correct for multiple comparisons by adjusting the FWE rate to α = 0.05 (two-tailed) using 408 
permutation tests (puncorr = 3.35 x 10
-03, with tuncorr = 2.93). We define replication success 409 
as observing a statistically significant effect at the 5% level (corrected for multiple 410 
hypothesis testing) in the same direction as the original finding51. 411 
Comparison of VBM Results with a Meta-Analysis of Functional MRI (fMRI) 412 
Studies. We compare our VBM results with a publicly available meta-analysis of fMRI 413 
studies provided by Neurosynth30, an online platform for large-scale, automated 414 
synthesis of fMRI data (https://neurosynth.org/). The meta-analysis was based on the 415 
keyword ‘risky’. It consisted of K = 101 individual studies with a total of N = 4,717 416 
participants (see Supplementary Table 9 for details), and was conducted using a 417 
uniformity test (assuming that random activations are evenly distributed across all 418 
voxels). The meta-analytic statistical image was corrected for multiple comparisons by 419 
applying a false discovery rate (FDR) of .01 (implemented by Neurosynth). The 420 
summary of studies included in the meta-analysis is available on Supplementary Table 421 
9. The 3D activation map that resulted from the meta-analysis is available on 422 
https://neurosynth.org/analyses/terms/risky/. To compare our VBM results (i.e., brain 423 
structure) with the meta-analysis of data on brain function, we perform a whole-brain 424 




the spatial overlap of all voxels that are significant in both analyses (Figure 4). Thus, 426 
both the structure and function of the brain regions identified by this conjunction are 427 
significantly associated with risky behaviour.  428 
Voxel-based Morphometry (VBM) Analysis of Risky Behaviour PRS. We repeat the 429 
VBM analysis in all voxels identified to be associated with risky behaviour, using the 430 
PRS as the dependent variable. This approach allows the identification of brain regions 431 
that were likely to mediate the effect of genetic disposition on risky behaviour. The PRS 432 
was constructed using GWAS results from an independent sample, to ensure that the 433 
effect size estimates in this analysis are not inflated due to overfitting. We account for 434 
multiple comparisons using a permutation test with an FWE rate of pFWE < 0.05. This 435 
part of the analysis was not pre-registered. 436 
Mediation Analysis. We conduct mediation analyses (implemented in STATA 14) to 437 
test whether GMV differences in the brain regions whose GMVs are associated with the 438 
PRS of risky behaviour (right dlPFC, right putamen and hypothalamus) mediate the 439 
association between the PRS and risky behaviour. We first extract GMV from these 440 
three ROIs using the same unbiased masks as in the ROI-level analysis (see 441 
Supplementary Methods 1.3.3). Then, we estimate a structural equation model (SEM) to 442 
quantify the effect of the PRS on risky behaviour mediated via GMV differences in these 443 
ROIs. All SEM equations include the aforementioned standard control variables (listed 444 
in Supplementary Methods 1.2). We carry out an additional robustness check by 445 
estimating an SEM that assumes one single path (i.e., the sum of all ROIs), which yields 446 
the same pattern of results (see Extended Data Figure 8). 447 
Family-Wise-Error Correction using Permutation Tests. To account for multiple 448 
hypothesis testing, we determine the appropriate FWE corrected p-value threshold with 449 




1,000 datasets with randomly permuted phenotypes (i.e., breaking the link between the 451 
outcome and explanatory variables), estimated regression models for all IDPs per 452 
analysis, and recorded the lowest p-value of each run to generate an empirical 453 
distribution of the test statistic under the null hypothesis. To obtain the FWE rate of any 454 
given alpha, we use the nth =  x 1000 lowest p-value from the 1,000 permutation runs 455 
as the FWE corrected p-value threshold. 456 
Pre-registration of Analysis Plan and Unplanned Deviations. We pre-registered our 457 
analysis plan on Open Science Framework (OSF, https://osf.io/qkp4g/, registered Dec. 458 
2018). Our pre-registered plan specified the construction of the dependent variable, the 459 
control variables, the inclusion criteria and quality controls, the VBM analyses and the 460 
main ROI-level analyses. We summarize all deviations from the analysis plan in 461 
Supplementary Methods 2. 462 
Data Availability 463 
Data and materials are available via UK Biobank at http://www.ukbiobank.ac.uk/. 464 
Code Availability 465 
The analysis code used in this study is publicly available on https://osf.io/qkp4g/. 466 
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Figure Legends 651 
Figure 1. | Main Sample Characteristics (N=12,675). (A) Geographical birth location 652 
clusters of the study’s participants. Each star represents the birthplace of a 653 
participant (non-jittered). Colours denote 100 geographical clusters, calculated using 654 
a k-means clustering algorithm with k = 100 and 10,000 iterations after random 655 
seeding. (B) Empirical distributions of variables in the main study sample. 656 
 657 
Figure 2. | Association between Risky Behaviour and Imaging-Derived Phenotypes 658 
(IDPs) of Grey Matter Volume (GMV). (A) Loadings for the first principal component are 659 
extracted from four self-reported measures of risky behaviour in the drinking, smoking, 660 
driving and sexual domains (N = 315,855) (see Figure 1 for descriptive statistics). We 661 
use this first principal component as a measure of risky behaviour. (B) Voxel-level GMV 662 
negatively associated with risky behaviour (N = 12,675). We observe associations in 663 
subcortical areas, including thalamus, posterior hippocampus, amygdala, putamen, 664 
ventral striatum and cerebellum. Associations with cortical areas include posterior 665 
middle temporal gyrus, precentral gyrus, dlPFC, anterior insula and vmPFC. (C) 666 
Associations between risky behaviour and GMV in 148 regions of interest (ROIs)` (N = 667 
12,675). The grey dotted line shows the FWE corrected threshold of P = 0.01 (see 668 
Methods for details). 669 
 670 
Figure 3 | Voxel-level Grey Matter Volumes (GMV) associated with risky 671 




in our original analysis (located in 20 out of 21 original clusters identified, 673 
marked in purple) successfully replicate (corrected for multiple testing at the 5% 674 
level using a permutation test). Non replicated voxels are located in the 675 
cerebellar lobules I-IV (marked in blue).  676 
 677 
 678 
Figure 4 | Conjunction between the Grey Matter Volume (GMV) differences 679 
associated with risky behaviour identified in the current study and the results of a 680 
meta-analysis of 101 fMRI studies, based on the keyword “risky”. This analysis 681 
identifies overlapping voxels in the thalamus, amygdala, vmPFC and dlPFC (see 682 
Methods for details). 683 
 684 
 685 
Figure 5. | Association of Polygenic Risk Scores (PRS) for Risky Behaviour and 686 
Grey Matter Volume (GMV). (A) We constructed a PRS of risky behaviour from a 687 
GWAS in an independent sample (N=297,025) and investigated its associations with 688 
GMV in brain voxels that we identified as linked to risky behaviour. The PRS 689 
negatively correlates with GMV in the right dlPFC, putamen and hypothalamus. (B) 690 
GMV differences in hypothalamus (path 1, designated as a1 and b1), right putamen 691 
(path 2, designated as a2 and b2) and right dlPFC (path 3, designated as a3 and b3) 692 
mediate ~2.2% of the association between the PRS and risky behaviour. Arrows 693 
depict the direction of the structural equation modelling and do not imply causality (N 694 

















10°W  5°W  0°
Longitude
 50 mi 
 100 km 
a b
N = 315,855Risky 
Behaviour
SmokingDrinking Speeding Sexual Behaviour
.54 .49 .41 .55
Ever smoked 
(yes/no)
Driving faster than the 
speed limit 
(6-point scale)












Frontal Lobe Occipital Lobe Parietal Lobe Subcortical Structures Temporal Lobe































































































































β = −.045, P < 3.3×10 -05
Direct Path c
β = .169, P = 4.8×10-86
Indirect Path c’









β = −.023, P < 1.4×10-03
Direct Path b














Frontal Lobe Occipital Lobe Parietal Lobe Subcortical Structures Temporal Lobe






























































































Frontal Lobe Occipital Lobe Parietal Lobe Subcortical Structures Temporal Lobe













































 FWE corrected threshold  (p < 0.05)
Frontal Lobe
Occipital Lobe
Parietal Lobe
Subcortical Structures
Temporal Lobe
positive coefficient
negative coefficient


